Aptamer of methotrexate, aptamer derivative and application of aptamer and aptamer derivative
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- EAST CHINA NORMAL UNIV
- Publication Date
- 2021-08-13
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to a nucleic acid aptamer, nucleic acid aptamer derivatives and applications thereof, in particular to a nucleic acid aptamer capable of binding methotrexate, a nucleic acid aptamer derivative and its ability to recognize and bind methotrexate Application of pterin. Background technique
[0002] Methotrexate (MTX), a folic acid antagonist, is widely used in the clinical treatment of various cancers and inflammatory diseases. According to reports, nearly 700 kinds of cancer cells are sensitive to MTX, among which acute lymphoblastic leukemia cell lines and acute myeloid leukemia cell lines are the most sensitive to MTX. MTX can interfere with the synthesis of tetrahydrofolate, thereby inhibiting the synthesis of DNA and RNA in cells, thus playing an anti-tumor effect. However, MTX has the problems of narrow therapeutic window and large toxic and side effects. The adverse reactions induced by high-dose methotrexate (HDMTX)...